Atsena Therapeutics vs Sensorion
Atsena Therapeutics
Clinical-stage gene therapy company developing treatments to reverse/prevent blindness from inherited retinal diseases
46 employees · est. 2019
Sensorion
Our mission: find solutions for hearing disorders
85 employees · est. 2009 · Montpellier, France
Sensorion is the older company (2019 vs 2009); Sensorion is the larger of the two.
Side-by-Side Comparison
| Metric | Atsena Therapeutics | Sensorion |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2009 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Montpellier, France |
| Employees | ||
| Employees | 46 | 85 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series C | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $237.62M | $98.25M |
| Funding Rounds | ||
| Funding Rounds | 5 | 5 |
| Taxonomy | ||
| Taxonomy | Clinical-stage CompanyOcular Gene TherapyInherited BlindnessATSN-201ATSN-101LCA1 +9 | Clinical-stage DevelopmentTherapeutic SolutionsHearing DisordersGene TherapyMonogenic DeafnessInner Ear Disorders +8 |
| Website | ||
| Website | atsenatx.com | sensorion.com |
About Atsena Therapeutics
Atsena Therapeutics is a biotechnology startup focusing on clinical-stage ocular gene therapy for treating inherited forms of blindness. The company's flagship programs include ATSN-201 for X-linked retinoschisis (XLRS) and ATSN-101 for GUCY2D-associated Leber congenital amaurosis (LCA1). Notably, t...
About Sensorion
Sensorion is a clinical-stage biotechnology company founded in 2009, with a mission to find solutions for hearing disorders. The company's clinical-stage portfolio includes SENS-401 (Arazasetron), a Phase 2 product being studied in Cisplatin-Induced Ototoxicity (CIO) and in patients scheduled for co...
Also comparing in this category
Comparing more than these two?
Get Atsena Therapeutics, Sensorion and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Atsena Therapeutics compare?
A PDF of Atsena Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Atsena Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Atsena Therapeutics on 9 Jun 2026, and Sensorion on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
